The Haunted Pipeline: Why Dead Deals Keep Coming Back

Oct 23, 2026

Amy Cook

Win more with Fullcast

haunted pipeline

The deal was supposed to close in March.

Then April. Then June.

Now it’s October, and somehow it’s still sitting in the pipeline with a 75% probability of closing.

Nobody has heard from the buyer in weeks. The champion changed jobs. The budget disappeared. But the forecast looks great.

You’re feeling the chill of a haunted pipeline, where dead opportunities refuse to leave the CRM, and optimistic forecasts keep them alive.

Forrester Research found that organizations that excel at lead nurturing generate 50% more sales-ready leads at a 33% lower cost. However, additional research shows that only 25% of leads are legitimate and should advance to sales.

There’s a difference between lead nurture and not breathing. 

The problem isn’t necessarily that sales teams are hiding bad deals. It’s that the warning signs often appear long before anyone updates the CRM. And by the time leadership realizes what’s happening, the forecast may already be in trouble.

Your Pipeline Might Be Full of Zombies

Not every open opportunity represents a realistic chance of winning revenue. Yet they remain in the pipeline, contributing to coverage ratios and forecast expectations. These are zombie opportunities: deals that look alive in the system but show little evidence of meaningful progress.

A healthy pipeline requires an honest assessment of which deals are moving, which are deteriorating, and which should no longer be counted on. Fullcast’s 2026 GTM Benchmarks Report highlights the importance of pipeline quality, not simply pipeline quantity, in driving revenue performance. Because a bigger pipeline isn’t necessarily a healthier pipeline. Sometimes it’s just a more crowded graveyard.

The CRM Doesn’t Know Everything

Perhaps the prospect expressed concern about implementation costs. Maybe procurement raised objections, an executive sponsor stopped attending meetings, or the buyer postponed the next step without committing to a new date. Yes, those details matter. But they’re often buried in meeting recordings, emails, notes, or conversations that never make it into structured CRM fields. That’s where traditional pipeline inspection can fall short.

Managers inspect opportunity stages, close dates, amounts, and rep updates. Yet some of the most revealing signals may exist outside those fields.

AskElephant: The Conversation Your CRM Forgot

This is where Fullcast’s acquisition of AskElephant becomes particularly interesting.

In his announcement welcoming AskElephant to Fullcast, CEO Ryan Westwood explained how the acquisition brings conversational intelligence and workflow automation into the company’s broader revenue platform.

AskElephant helps capture important customer context, automate follow-up workflows, and keep CRM information aligned with what happens in conversations. Consider what that means for pipeline management.

A seller might report that a deal is on track while the most recent customer conversation reveals unresolved objections, uncertain timing, or missing stakeholder support. Capturing that information creates an opportunity to identify risks earlier, improve CRM accuracy, and give managers better evidence for coaching and inspection.

Stop Asking Whether the Rep Feels Good About the Deal

Every sales forecast meeting eventually reaches a familiar moment. The manager asks, “How confident are you?” The rep says, “Pretty confident.” And somewhere, a spreadsheet quietly accepts this as evidence.

Seller judgment matters. Experienced account executives often recognize subtle changes in buyer behavior. But confidence alone isn’t a forecasting methodology. Revenue leaders need to examine whether the buyer is demonstrating meaningful commitment.

For instance, are decision-makers engaged? Are next steps confirmed? Have objections been addressed? Is the opportunity progressing at a pace consistent with its projected close date?

This is where Fullcast’s revenue intelligence capabilities can help teams examine engagement, deal health, and pipeline risk. AskElephant adds another important dimension by capturing customer conversation context and the workflows that help translate that context into action.

Together, these capabilities support a more informed approach to pipeline inspection that is grounded in what buyers are actually doing and saying.

Your Forecasting Problem May Have Started Months Ago

The truth is, pipeline problems rarely appear overnight. They accumulate. A lead reaches the wrong rep. Follow-up is delayed. An opportunity enters the pipeline without sufficient qualification. The buyer loses interest. The close date moves. And moves again.

By the time the CRO asks why the forecast missed, the original problem may be buried beneath months of CRM activity. That’s why pipeline health isn’t exclusively a sales management responsibility. It’s connected to territory planning, lead routing, seller capacity, opportunity management, and customer engagement. A connected revenue operating model makes it easier to examine those relationships rather than treating each missed forecast as an isolated event.

How to Spot a Haunted Opportunity

RevOps leaders don’t need supernatural powers to recognize pipeline risk. They need visibility into the right signals.

Watch for opportunities with:

  • Repeated close-date changes without meaningful progress.
  • Long periods without buyer engagement.
  • Missing decision-makers or weakened stakeholder relationships.
  • No confirmed next meeting or mutual action plan.
  • Unresolved objections that never appear in CRM updates.
  • Forecast confidence that doesn’t match observable buyer behavior.

No single signal automatically means a deal is lost. But a combination should prompt investigation rather than another optimistic forecast adjustment. The objective isn’t to punish sellers for struggling opportunities. It’s to identify where intervention can still make a difference and where the forecast needs to reflect reality.

Stop Forecasting the Living Dead

Revenue leaders don’t need every opportunity to close. But they do need to know which opportunities have a credible path to closing. That requires a clearer connection between CRM data, customer conversations, pipeline inspection, and the actions sellers take next.

Fullcast’s broader revenue platform brings planning, execution, performance intelligence, and compensation into a connected revenue process. The addition of AskElephant strengthens the conversation-to-execution connection.

Because the most valuable pipeline intelligence doesn’t simply tell you a deal is in trouble. It helps your team understand why and what to do next. The dead deals can stay in the CRM for historical reporting. They just shouldn’t keep showing up in the forecast wearing a fake mustache.

________________

Four key takeaways

  1. What is a zombie opportunity in sales? A zombie opportunity is a deal that remains open in the CRM despite limited buyer engagement, repeated delays, or insufficient evidence that it will close.
  2. Why can CRM data create misleading sales forecasts? CRM records may not reflect objections, stakeholder changes, or buying signals revealed in customer conversations, leaving managers with an incomplete picture of deal health.
  3. How can AskElephant improve pipeline visibility? AskElephant’s conversational intelligence and workflow automation can help capture customer context, support CRM accuracy, and surface information relevant to deal inspection and follow-up.
  4. How does revenue intelligence help identify pipeline risk? Revenue intelligence helps teams evaluate engagement, opportunity progression, relationship strength, and deal health so they can identify risks earlier and make more informed forecasting decisions.

Amy Cook

Amy Osmond Cook, Ph.D., is a seasoned marketing executive and communications expert, recognized for her innovative strategies in technology, healthcare and real estate marketing. She is the co-founder and Chief Marketing Officer of Fullcast, the Go-to-Market Cloud, and has a proven track record helping multiple high-growth companies move from series A through acquisition (Simplus, 2020; PathologyWatch, 2023; Onboard, 2024). Amy founded and led Stage Marketing as CEO for 15 years, building it into a leading full-funnel marketing firm. With a Ph.D. in Communication from the University of Utah, Amy has authored numerous articles and served as a prominent voice in business and healthcare communities. Her passion for empowering others is evident in her work and community involvement. She and her husband, Jeff, have five children.